Additionally, a recent meta-analysis about pregnant women with myeloproliferative neoplasms suggests that the use of IFN-β during pregnancy was associated with higher successful pregnancy than observation alone, which may be attributed to the potential antiproliferative properties of IFN in myeloproliferative neoplasms (52). Here, IFNA1 is linked to myeloproliferative neoplasm.